Filana Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	86.57	95.5	128.57	121.14	201.02	233.44
Cash & Short-Term Investments	86.57	95.5	128.57	121.14	201.02	233.44
Cash Growth	-26.21%	-25.72%	6.14%	-39.74%	-13.89%	149.65%
Other Current Assets	1.39	2.21	7.96	8.5	10.21	11.05
Total Current Assets	87.96	97.71	136.53	129.63	211.23	244.48
Net Property, Plant & Equipment	20.4	20.65	21	21.85	22.99	20.83
Other Intangible Assets	-	-	-	0.18	0.62	1.08
Other Long-Term Assets	-	-	-	-	-	0.4
Total Assets	108.37	118.36	157.53	151.66	234.83	266.78
Accounts Payable	39.19	41.65	7.65	10.57	4.02	7.13
Accrued Expenses	0.85	1.99	3.8	3.24	2.45	4.68
Current Portion of Leases	-	-	-	-	0.1	0.1
Other Current Liabilities	0.08	0.2	0.3	0.39	0.49	0.63
Total Current Liabilities	40.12	43.83	11.75	14.2	7.06	12.53
Long-Term Leases	-	-	-	-	0.04	0.14
Other Long-Term Liabilities	0.11	0.12	0.08	-	0.2	0.19
Total Long-Term Liabilities	0.11	0.12	0.08	-	0.23	0.33
Total Liabilities	40.23	43.95	11.83	14.2	7.3	12.87
Common Stock	0.05	0.05	0.05	0.04	0.04	0.04
Additional Paid-in Capital	574.51	570.44	550.77	518.2	511.05	461.18
Retained Earnings	-506.42	-496.08	-405.11	-380.77	-283.55	-207.31
Shareholders' Equity	68.14	74.4	145.7	137.47	227.54	253.92
Total Liabilities & Equity	108.37	118.36	157.53	151.66	234.83	266.78
Total Debt	-	0	0	0	0.14	0.24
Net Cash (Debt)	86.57	95.5	128.57	121.14	200.88	233.2
Net Cash Growth	-9.35%	-25.72%	6.14%	-39.70%	-13.86%	150.18%
Net Cash Per Share	1.79	1.98	2.76	2.89	5.00	5.92
Book Value	68.14	74.4	145.7	137.47	227.54	253.92
Book Value Per Share	1.41	1.54	3.13	3.28	5.66	6.44
Tangible Book Value	68.14	74.4	145.7	137.29	226.92	252.84
Tangible Book Value Per Share	1.41	1.54	3.13	3.27	5.64	6.42

SEC Filings: 10-K · 10-Q